The North America lab-on-a-chip and microarrays (biochip) market is expected to register a healthy CAGR of 16.1% during the forecast period. Increasing application of proteomics and genomics in cancer research, growth of personalized medicine, favorable regulatory approval for personalized medicine, increased commercial application of biochips are the major factors that are driving the North America lab-on-a-chip and microarrays (biochip) market.
Microarrays (biochips) has been the technology of choice for large-scale studies of gene expression since their invention in the 1990s. Although microarray technology continues to advance, transcriptomics has expanded dramatically in the past few years, owing to the availability of new alternative technology, such as RNA-sequencing (RNA-seq) and Next Generation Sequencing (NGS).
Both sensitivity and specificity can be low with microarray technology. Moreover, accuracy can be negatively affected, owing to a low dynamic range of the existing microarrays. Background hybridization limits the accuracy of expression measurements, especially for transcripts present in small amounts. Probes also differ considerably in their hybridization properties. Microarrays are limited to interrogating only those genes for which probes are designed. Although microarray technology has its advantages (less labor intensive and economical), the availability of alternative technologies and their benefits in comparison with microarrays is restraining the growth of lab-on-a-chip and microarrays (biochip) market. The other factors, such as low commercial acceptability due to the high costs and lack of skilled labor is also hindering the market.
Key Market Trends
Microarray are Anticipated to Hold Significant Share in the Studied Market
Microarray is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a two-dimensional array of reagents, genes, or specimen placed in defined positions on the surface of a chip provided with thousands of minute pores. It is a laboratory tool used to detect the expression of thousands of genes at the same time. Microarrays are the most popular form of Lab-on-a-Chip technology, due to the wide range of differentiation and low price of the equipment. Increasing use of personal medical devices and the need for immediate results from diagnostic tests are the greatest factors driving the demand for microarrays in the lab-on-a-chip market. But with the use of microarrays and other lab-on-chip solutions, many pre-analytical and post-analytical errors could be eliminated, as lab-on-chip provides highly portable and modular solutions that could be handled easily and provide instant results, leading to faster diagnosis for the patients and higher throughputs to the lab owners. With further enhancements in the microarray technology and increasing awareness of lab-on-chip solutions in developing countries, the market is expected to witness considerable growth over the forecast period.
The North America Lab-on-a-chip and Microarrays (Biochip) market, which is highly competitive, consists of a few major players. In terms of market share, few of the major players currently dominate the market. Companies, such as Abbott Laboratories Bio-Rad Laboratories, GE Healthcare, Roche Holding AG among others, hold a substantial market share in the Lab-on-a-chip and Microarrays (Biochip) market.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support